General Information of Drug (ID: DMMI4KQ)

Drug Name
PMID27109571-Compound-11 Drug Info
Cross-matching ID
TTD Drug ID
DMMI4KQ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID27109571-Compound-27 DMXRTH4 N. A. N. A. Patented [1]
PMID27109571-Compound-31 DMU690T N. A. N. A. Patented [1]
PMID27109571-Compound-16 DMZI25U N. A. N. A. Patented [1]
PMID27109571-Compound-14 DMVY6B9 N. A. N. A. Patented [1]
PMID27109571-Compound-25 DM435GR N. A. N. A. Patented [1]
PMID27109571-Compound-30 DM24FSP N. A. N. A. Patented [1]
PMID27109571-Compound-29 DMDMEHQ N. A. N. A. Patented [1]
PMID27109571-Compound-18 DM4S5ME N. A. N. A. Patented [1]
PMID27109571-Compound-28 DMTZVY3 N. A. N. A. Patented [1]
PMID27109571-Compound-20 DMQU9XP N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fatty acid-binding protein 4 (FABP4) TTHWMFZ FABP4_HUMAN Inhibitor [1]

References

1 Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015).Expert Opin Ther Pat. 2016 Jul;26(7):767-76.